Search
forResearch 3 of 20
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia
- PROTACs: A novel strategy for cancer drug discovery and development
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →